Patent USRE29182E successfully refreshed from Google Patents.
USRE29182E
Expired / Lapsed
US
⏱️ 0.0 years remaining
Oral composition for calculus retardation
Assignee: Procter and Gamble Co
•
Filing: 1976-06-14
•
Granted: 1977-04-12
•
Expires: 1996-06-14
Abstract
Abstract Oral compositions, such as toothpaste, mouthwash, and the like, containing certain polyphosphonic acids and their salts which retard dental calculus formation without damaging tooth structure.
Inventors
- 👤 Homer W. McCune
- 👤 Nathaniel B. Tucker
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 17:49
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/28; C07F9/38; C07F9/3804; C07F9/3839; A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/55; A61Q; A61Q11/00
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
214 words
.[.An oral.]. .Iadd.A dentifrice .Iaddend.composition effective in inhibiting the formation of dental calculus without adversely affecting tooth structure, comprising (1) from about .01% to about 10% by weight of a polyphosphonate selected from the group consisting of those of the formulae: ##STR3##wherein R 1 and R 2 are each hydrogen or CH 2 OH; n is an integer of from 3 to 10; R 3 is hydrogen, alkyl containing from 1 to about 20 carbon atoms, alkenyl containing from 2 to about 20 carbon atoms, phenyl, naphthyl, phenylethyl, benzyl, halogen, amino, dimethylamino, diethylamino, N-hydroxy-N-ethylamino, acetylamino, --CH 2 COOH --CH 2 PO 3 H 2 , --CH(PO 3 H 2 )(OH) or --CH 2 CH(PO 3 H 2 ) 2 R 4 is hydrogen, lower alkyl, amino, benzyl, halogen, hydroxyl --CH 2 COOH, CH 2 PO 3 H 2 , or --CH 2 CH 2 PO 3 H 2 ; or a pharmaceutically acceptable salt thereof, and (2) .[.a carrier suitable for use in the oral cavity,.]. .Iadd.from about 0.5% to 95% by weight of an abrasive material, .Iaddend.the pH of the compositon being within the range from about 5.0 to 11.0, .Iadd.said composition being free of calcium abrasives which would yield enough soluble calcium to significantly impair the anticalculus activity of said polyphosphonate. .Iaddend.
Claim 2
Dependent Claim
214 words
.[.An oral.]. .Iadd.A dentifrice .Iaddend.composition effective in inhibiting the formation of dental calculus without adversely affecting tooth structure, comprising (1) from about .01% to about 10% by weight of a polyphosphonate selected from the group consisting of those of the formulae: ##STR3##wherein R 1 and R 2 are each hydrogen or CH 2 OH; n is an integer of from 3 to 10; R 3 is hydrogen, alkyl containing from 1 to about 20 carbon atoms, alkenyl containing from 2 to about 20 carbon atoms, phenyl, naphthyl, phenylethyl, benzyl, halogen, amino, dimethylamino, diethylamino, N-hydroxy-N-ethylamino, acetylamino, --CH 2 COOH --CH 2 PO 3 H 2 , --CH(PO 3 H 2 )(OH) or --CH 2 CH(PO 3 H 2 ) 2 R 4 is hydrogen, lower alkyl, amino, benzyl, halogen, hydroxyl --CH 2 COOH, CH 2 PO 3 H 2 , or --CH 2 CH 2 PO 3 H 2 ; or a pharmaceutically acceptable salt thereof, and (2) .[.a carrier suitable for use in the oral cavity,.]. .Iadd.from about 0.5% to 95% by weight of an abrasive material, .Iaddend.the pH of the compositon being within the range from about 5.0 to 11.0, .Iadd.said composition being free of calcium abrasives which would yield enough soluble calcium to significantly impair the anticalculus activity of said polyphosphonate. .Iaddend.
Claim 3
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is ethane-1-hydroxy-1,1-diphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is methanediphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is methanedichlorodiphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 6
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is ethane-1-hydroxy-1,1,2-triphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is methanehydroxydiphosphonic acid or a pharamaceutically acceptable salt thereof.
Claim 8
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is propane-1,1,3,3-tetraphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is ethane-2-carboxy-1,1-diphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 10
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is ethane-1,1,2-triphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 11
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is ethane-1-amino-1,1-diphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 12
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is ethanedichlorodiphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 13
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is nonane-5,5-diphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 14
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is n-pentane-1,1-diphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 15
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is methanedibromodiphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 16
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is propane-1-hydroxy-1,1,3-triphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 17
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is propane-1,2,3-triphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 18
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is butane-1,2,3,4-tetraphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 19
Dependent Claim
18 words
The composition of claim 1 in which the polyphosphonate is hexane-1,2,3,4,5,6-hexaphosphonic acid or a pharmaceutically acceptable salt thereof.
Claim 20
Dependent Claim
192 words
A toothpaste composition comprising (1) from about 0.1% to about 5.0% by weight of a polyphosphonate selected from the group consisting of those of the formulae: ##STR4##wherein R 1 and R 2 are each hydrogen or CH 2 OH; n is an integer of from 3 to 10; R 3 is hydrogen, alkyl containing from 1 to about 20 carbon atoms, alkenyl containing from 2 to about 20 carbon atoms, phenyl, naphthyl, phenylethenyl, benzyl, halogen, amino, dimethylamino, diethylamino, N-hydroxy-N-ethylamino, acetylamino, --CH 2 COOH --CH 2 PO 3 H 2 , --CH(PO 3 H 2 )(OH) or --CH 2 CH(PO 3 H 2 ) 2 R 4 is hydrogen, lower alkyl, amino, benzyl, halogen, hydroxyl, --CH 2 COOH, --CH 2 PO 3 H 2 , or --CH 2 CH 2 PO 3 H 2 ; or a pharmaceutically acceptable salt thereof, and (2) from about 20% to about 60% by weight of an abrasive material, the pH of said composition being within the range from about 7 to about 10, .Iadd.said composition being free of calcium abrasives which would yield enough soluble calcium to significantly impair the anticalculus activity of said polyphosphonate. .Iaddend.
Claim 21
Dependent Claim
192 words
A toothpaste composition comprising (1) from about 0.1% to about 5.0% by weight of a polyphosphonate selected from the group consisting of those of the formulae: ##STR4##wherein R 1 and R 2 are each hydrogen or CH 2 OH; n is an integer of from 3 to 10; R 3 is hydrogen, alkyl containing from 1 to about 20 carbon atoms, alkenyl containing from 2 to about 20 carbon atoms, phenyl, naphthyl, phenylethenyl, benzyl, halogen, amino, dimethylamino, diethylamino, N-hydroxy-N-ethylamino, acetylamino, --CH 2 COOH --CH 2 PO 3 H 2 , --CH(PO 3 H 2 )(OH) or --CH 2 CH(PO 3 H 2 ) 2 R 4 is hydrogen, lower alkyl, amino, benzyl, halogen, hydroxyl, --CH 2 COOH, --CH 2 PO 3 H 2 , or --CH 2 CH 2 PO 3 H 2 ; or a pharmaceutically acceptable salt thereof, and (2) from about 20% to about 60% by weight of an abrasive material, the pH of said composition being within the range from about 7 to about 10, .Iadd.said composition being free of calcium abrasives which would yield enough soluble calcium to significantly impair the anticalculus activity of said polyphosphonate. .Iaddend.
Claim 22
Dependent Claim
47 words
The composition of claim 19 in which the polyphosphonate is ethane-1-hydroxy-1,1-diphosphonic acid or a pharmaceutically acceptable salt thereof. .Iadd.21. The composition of claim 19 wherein the abrasive material is selected from the group consisting of β-phase calcium pyrophosphate, thermosetting polymerized resins, alumina and insoluble non-calcium metaphosphates. .Iaddend.
References Cited (Backward Citations)
US2191199A
Cited
US3214454A
Cited
US3303139A
Cited
US3159581A
Cited
US3213030A
Cited
US3299123A
Cited
US3297578A
Cited
US3671644A
Cited
US3400148A
Cited
US3400176A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-04-11 | 1980-10-11 | 1981-04-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-04-11 | 1984-10-11 | 1985-04-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-04-11 | 1988-10-11 | 1989-04-12 | $7700.00 | Window Closed / Lapsed |